Ms Debra Lee Suierveld, LSW | |
317 Young Dr, Apollo, PA 15613-9677 | |
(724) 727-2177 | |
Not Available |
Full Name | Ms Debra Lee Suierveld |
---|---|
Gender | Female |
Speciality | Social Worker - Clinical |
Location | 317 Young Dr, Apollo, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104022698 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | SW008460-L (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Debra Lee Suierveld, LSW 317 Young Dr, Apollo, PA 15613-9677 Ph: (724) 727-2177 | Ms Debra Lee Suierveld, LSW 317 Young Dr, Apollo, PA 15613-9677 Ph: (724) 727-2177 |
News Archive
New research published in the March 3, 2009, issue of the Journal of the American College of Cardiology finds that anger-induced electrical changes in the heart can predict future arrhythmias in patients with implantable cardioverter-defibrillators (ICDs).
A new study has confirmed that the drug, ivacaftor (VX-770), significantly improves lung function in some people with cystic fibrosis (CF). The results of the phase III clinical trial study, "A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation," led by Bonnie W. Ramsey, MD of Seattle Children's Research Institute and the University of Washington, were published today in the New England Journal of Medicine.
Response Biomedical Corporation today announced that Roche Diagnostics has terminated, effective September 30, 2011, the sales and distribution agreement between Roche and Response dated June 25, 2008. Under the terms of that agreement and related agreements, Roche Diagnostics had agreed to distribute Response's cardiovascular point-of-care (POC) tests on the RAMPĀ® 200 Reader in the US.
Lifting weights can provide significant health benefits to patients suffering from kidney disease.
Scientists at the University of Bonn and the caesar research center have isolated a molecule that might open new avenues in the fight against SARS coronavirus 2. The active ingredient binds to the spike protein that the virus uses to dock to the cells it infects.
› Verified 9 days ago